Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Michael Verneris

Concepts (666)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cell Transplantation
95
2023
519
15.460
Why?
Killer Cells, Natural
52
2020
380
8.130
Why?
Graft vs Host Disease
52
2022
212
7.510
Why?
Transplantation Conditioning
42
2021
149
6.010
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
37
2023
256
5.700
Why?
Cord Blood Stem Cell Transplantation
33
2021
91
5.300
Why?
Hematologic Neoplasms
27
2021
136
3.390
Why?
Leukemia, Myeloid, Acute
28
2022
533
3.180
Why?
Transplantation, Homologous
44
2022
377
3.060
Why?
Unrelated Donors
21
2021
37
2.890
Why?
Fetal Blood
15
2017
268
2.860
Why?
Leukemia
20
2023
208
2.840
Why?
Hematopoietic Stem Cells
9
2020
338
2.550
Why?
Myelodysplastic Syndromes
16
2020
119
2.080
Why?
Immunity, Innate
7
2021
720
1.960
Why?
Antibodies, Bispecific
5
2021
32
1.940
Why?
Cell Differentiation
13
2022
1696
1.750
Why?
Neoplasm, Residual
7
2021
104
1.640
Why?
Immunotherapy, Adoptive
21
2023
184
1.500
Why?
Bone Marrow Transplantation
12
2017
237
1.490
Why?
Haplotypes
4
2021
448
1.480
Why?
Recurrence
31
2023
925
1.460
Why?
Disease-Free Survival
29
2021
618
1.430
Why?
CD56 Antigen
9
2020
34
1.420
Why?
Humans
211
2023
114045
1.360
Why?
Child
88
2023
18401
1.350
Why?
Receptors, Antigen, T-Cell
13
2023
615
1.340
Why?
Young Adult
67
2023
10444
1.290
Why?
Child, Preschool
61
2022
9114
1.290
Why?
Adolescent
84
2022
17800
1.240
Why?
Antineoplastic Agents
12
2021
1875
1.240
Why?
HLA Antigens
9
2017
220
1.240
Why?
Interleukins
4
2015
236
1.210
Why?
Cytomegalovirus Infections
7
2019
180
1.170
Why?
Receptors, IgG
8
2019
67
1.160
Why?
Lymphoid Tissue
3
2021
62
1.130
Why?
T-Lymphocytes, Helper-Inducer
2
2019
127
1.090
Why?
Adult
93
2023
30375
1.090
Why?
Graft Survival
9
2018
443
1.080
Why?
Immunotherapy
9
2021
473
1.070
Why?
Cell- and Tissue-Based Therapy
3
2021
56
1.060
Why?
Infant
47
2022
7943
1.050
Why?
Lymphocytes
6
2020
327
1.030
Why?
Cytokines
10
2018
1824
1.010
Why?
Virus Activation
4
2019
78
0.990
Why?
Receptors, KIR
9
2015
92
0.990
Why?
Antigens, CD
6
2019
440
0.990
Why?
Male
109
2021
55396
0.980
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
2023
64
0.970
Why?
Survival Analysis
23
2020
1206
0.960
Why?
Cryopreservation
2
2017
92
0.960
Why?
Female
112
2021
59324
0.950
Why?
Treatment Outcome
44
2021
9049
0.950
Why?
Histocompatibility Testing
10
2018
115
0.940
Why?
Whole-Body Irradiation
8
2018
72
0.940
Why?
Middle Aged
71
2021
26605
0.920
Why?
Tissue Donors
9
2019
314
0.900
Why?
Pluripotent Stem Cells
2
2022
64
0.890
Why?
Adoptive Transfer
4
2017
194
0.880
Why?
Histocompatibility
6
2019
26
0.870
Why?
Cytomegalovirus
8
2019
143
0.850
Why?
Stem Cell Transplantation
3
2019
148
0.830
Why?
Graft vs Leukemia Effect
3
2013
12
0.820
Why?
Peripheral Blood Stem Cell Transplantation
3
2018
19
0.810
Why?
Hemangioblasts
1
2022
4
0.810
Why?
Lymphocyte Depletion
5
2019
115
0.800
Why?
HLA-C Antigens
3
2016
33
0.790
Why?
Receptors, Immunologic
6
2016
198
0.770
Why?
Lymphoid Progenitor Cells
2
2020
11
0.760
Why?
Interferon-gamma
9
2014
719
0.740
Why?
Signaling Lymphocytic Activation Molecule Family
1
2020
3
0.730
Why?
CD48 Antigen
1
2020
2
0.730
Why?
Bone Marrow
9
2017
243
0.730
Why?
Receptors, Prolactin
1
2020
8
0.700
Why?
Leukemia, Myeloid
2
2017
40
0.690
Why?
Smad7 Protein
1
2020
18
0.690
Why?
Antigens, CD19
10
2023
91
0.690
Why?
Lymphopoiesis
1
2020
24
0.690
Why?
Burkitt Lymphoma
4
2023
52
0.680
Why?
Monocytes
3
2020
503
0.680
Why?
Bone Neoplasms
3
2010
191
0.680
Why?
Prolactin
1
2020
96
0.670
Why?
Cell Proliferation
12
2019
2173
0.670
Why?
Transplantation Chimera
2
2019
51
0.660
Why?
Crohn Disease
1
2022
196
0.660
Why?
Transplantation, Autologous
4
2019
175
0.650
Why?
Cells, Cultured
15
2022
3861
0.650
Why?
Interleukin-2
5
2019
413
0.650
Why?
Transforming Growth Factor beta1
1
2020
153
0.640
Why?
Sarcoma, Ewing
3
2010
65
0.640
Why?
GATA3 Transcription Factor
1
2019
24
0.640
Why?
Interleukin-15
5
2019
74
0.640
Why?
T-Lymphocytes
11
2023
1735
0.630
Why?
Aged
46
2021
18969
0.630
Why?
Retrospective Studies
35
2023
12521
0.620
Why?
Survival Rate
18
2020
1638
0.620
Why?
Inflammatory Bowel Diseases
1
2022
284
0.620
Why?
Allografts
13
2021
121
0.610
Why?
Adipokines
1
2018
42
0.610
Why?
Immune Reconstitution
1
2018
6
0.600
Why?
Piperazines
3
2009
310
0.600
Why?
Histocompatibility Antigens Class I
4
2019
170
0.600
Why?
Cell Lineage
3
2020
308
0.600
Why?
Delayed Graft Function
1
2018
26
0.600
Why?
Gene Expression Regulation
4
2019
2322
0.580
Why?
Pyrimidines
3
2009
374
0.580
Why?
T-Lymphocytes, Regulatory
4
2015
337
0.560
Why?
Acute Disease
17
2019
907
0.560
Why?
Blood Donors
4
2016
84
0.560
Why?
Antigens, CD34
4
2022
88
0.550
Why?
Stromal Cells
4
2011
96
0.550
Why?
Siblings
7
2019
220
0.540
Why?
Myeloid Progenitor Cells
2
2020
15
0.540
Why?
Time Factors
17
2019
6077
0.530
Why?
Prognosis
15
2021
3315
0.530
Why?
Neoplasms
9
2022
2086
0.530
Why?
Cell Degranulation
3
2013
39
0.530
Why?
Bone Marrow Cells
3
2020
266
0.520
Why?
Lymphocyte Activation
12
2016
1036
0.510
Why?
Lymphoma, B-Cell
4
2023
87
0.510
Why?
Pulmonary Embolism
2
2010
180
0.510
Why?
Receptors, Tumor Necrosis Factor, Member 25
1
2015
3
0.500
Why?
Tumor Necrosis Factor Ligand Superfamily Member 15
1
2015
8
0.500
Why?
Self Tolerance
2
2013
28
0.500
Why?
Mitochondria
4
2021
744
0.490
Why?
Up-Regulation
3
2015
802
0.490
Why?
Receptors, Calcitriol
1
2014
53
0.460
Why?
Calcitriol
1
2014
53
0.450
Why?
Mice
21
2023
14843
0.450
Why?
Recombinant Fusion Proteins
5
2021
613
0.450
Why?
Neoplasm Recurrence, Local
6
2018
850
0.450
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
2009
94
0.450
Why?
CD4-Positive T-Lymphocytes
3
2016
959
0.450
Why?
Donor Selection
4
2018
65
0.430
Why?
Mycophenolic Acid
3
2016
76
0.430
Why?
Chromosomes, Human, Pair 7
1
2013
15
0.430
Why?
Chromosomes, Human, Pair 5
1
2013
24
0.430
Why?
Vitamins
1
2014
150
0.430
Why?
Single-Chain Antibodies
1
2013
14
0.430
Why?
CD8-Positive T-Lymphocytes
6
2018
686
0.420
Why?
Immunophenotyping
8
2019
274
0.420
Why?
NK Cell Lectin-Like Receptor Subfamily C
4
2015
8
0.420
Why?
Cytotoxicity, Immunologic
10
2016
188
0.410
Why?
Metabolic Syndrome
1
2016
320
0.410
Why?
Chromosome Aberrations
1
2013
134
0.410
Why?
Remission Induction
9
2018
233
0.390
Why?
Immunosuppressive Agents
4
2015
641
0.390
Why?
Fibroblast Growth Factor 7
1
2011
16
0.390
Why?
Lymphocyte Count
4
2017
132
0.390
Why?
Carcinoma
1
2013
198
0.380
Why?
Cell Communication
1
2013
277
0.370
Why?
Animals
26
2023
31565
0.360
Why?
Lymphocyte Subsets
3
2021
79
0.350
Why?
Salvage Therapy
1
2011
127
0.350
Why?
Graft vs Tumor Effect
3
2017
8
0.350
Why?
Sialic Acid Binding Ig-like Lectin 3
3
2016
8
0.350
Why?
Body Mass Index
1
2018
1957
0.350
Why?
Incidence
8
2019
2314
0.350
Why?
Antineoplastic Combined Chemotherapy Protocols
9
2021
1356
0.350
Why?
Heparin
1
2011
225
0.350
Why?
K562 Cells
6
2014
73
0.340
Why?
Infant, Newborn
9
2019
5038
0.340
Why?
Antineoplastic Agents, Immunological
2
2021
152
0.330
Why?
Medical Oncology
1
2011
229
0.330
Why?
Cyclosporine
3
2016
161
0.320
Why?
Myeloablative Agonists
5
2016
21
0.320
Why?
Natural Cytotoxicity Triggering Receptor 3
1
2008
2
0.320
Why?
Influenza Vaccines
2
2016
497
0.310
Why?
Cytotoxicity Tests, Immunologic
1
2008
43
0.310
Why?
Philadelphia Chromosome
1
2008
15
0.310
Why?
Hematopoiesis
3
2020
170
0.310
Why?
Single-Cell Analysis
2
2020
186
0.310
Why?
Follow-Up Studies
9
2020
4392
0.300
Why?
Antibodies
5
2018
365
0.300
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2021
56
0.300
Why?
Lymphocyte Transfusion
3
2016
19
0.300
Why?
Gene Expression Regulation, Leukemic
2
2019
48
0.300
Why?
Risk Factors
18
2021
8614
0.300
Why?
Epidermal Growth Factor
3
2017
160
0.300
Why?
Natural Killer T-Cells
1
2008
63
0.300
Why?
Chronic Disease
6
2023
1577
0.290
Why?
Kaplan-Meier Estimate
6
2021
813
0.290
Why?
Cell Count
3
2014
303
0.290
Why?
Coculture Techniques
5
2020
198
0.290
Why?
GPI-Linked Proteins
4
2019
54
0.280
Why?
Polymorphism, Genetic
3
2016
610
0.280
Why?
Cell Line, Tumor
9
2016
2700
0.280
Why?
Alleles
4
2017
789
0.280
Why?
Immunologic Memory
4
2016
313
0.270
Why?
HLA-DP beta-Chains
2
2017
76
0.270
Why?
Hyperglycemia
2
2020
292
0.260
Why?
Peritoneal Dialysis
1
2007
84
0.260
Why?
Matrix Metalloproteinases
1
2007
89
0.260
Why?
Neuroblastoma
1
2007
133
0.260
Why?
Cell Separation
3
2020
290
0.260
Why?
Apoptosis
7
2011
2349
0.260
Why?
CD57 Antigens
3
2015
15
0.250
Why?
Heart Diseases
1
2009
329
0.250
Why?
Neoplasms, Experimental
2
2005
149
0.250
Why?
Blood Platelets
3
2021
326
0.250
Why?
Imatinib Mesylate
3
2009
63
0.240
Why?
Radiotherapy, Intensity-Modulated
3
2013
124
0.240
Why?
Hepatitis A Virus Cellular Receptor 2
2
2023
26
0.240
Why?
Chimerism
2
2021
28
0.240
Why?
Membrane Proteins
8
2015
1016
0.230
Why?
Diphtheria Toxin
2
2015
51
0.230
Why?
Cohort Studies
12
2021
4883
0.230
Why?
Neoplasm Proteins
3
2017
385
0.230
Why?
Benzamides
3
2009
168
0.230
Why?
Risk
3
2018
810
0.230
Why?
Drug Resistance, Neoplasm
3
2018
636
0.230
Why?
Neutrophils
4
2017
1089
0.220
Why?
Follistatin
3
2019
12
0.220
Why?
Major Histocompatibility Complex
2
2018
217
0.220
Why?
Mutation
4
2019
3338
0.220
Why?
Endoglin
3
2019
20
0.210
Why?
Protein Kinase Inhibitors
1
2009
784
0.210
Why?
Lymphohistiocytosis, Hemophagocytic
1
2023
28
0.210
Why?
Receptors, Natural Killer Cell
4
2014
16
0.210
Why?
Receptor, ErbB-2
1
2005
300
0.210
Why?
Practice Patterns, Physicians'
1
2011
1175
0.210
Why?
Flow Cytometry
5
2020
1075
0.210
Why?
fms-Like Tyrosine Kinase 3
2
2020
42
0.200
Why?
Signal Transduction
7
2020
4501
0.200
Why?
Maximum Tolerated Dose
3
2017
183
0.200
Why?
Severity of Illness Index
4
2021
2537
0.190
Why?
Proteins
4
2018
906
0.190
Why?
Leukemia, Myelomonocytic, Juvenile
1
2021
3
0.190
Why?
Polymorphism, Single Nucleotide
3
2018
1880
0.190
Why?
Genetic Variation
2
2017
868
0.190
Why?
Multivariate Analysis
5
2014
1422
0.190
Why?
Thrombopoietin
1
2021
4
0.190
Why?
CD3 Complex
2
2001
92
0.180
Why?
fas Receptor
2
2003
91
0.180
Why?
CD52 Antigen
1
2020
3
0.180
Why?
Carcinoma, Papillary
1
2001
74
0.180
Why?
Lymphoma
2
2003
176
0.180
Why?
Receptors, Fc
1
2021
45
0.180
Why?
Cell Survival
2
2014
1014
0.180
Why?
Heterografts
1
2021
117
0.180
Why?
Histone Deacetylase Inhibitors
1
2022
197
0.180
Why?
Osteosarcoma
1
2001
65
0.180
Why?
Anemia, Hemolytic, Autoimmune
1
2020
11
0.180
Why?
Cell Culture Techniques
4
2011
341
0.180
Why?
Gene Knockout Techniques
1
2020
98
0.180
Why?
Graft Rejection
4
2021
511
0.180
Why?
Primary Cell Culture
1
2020
148
0.170
Why?
Neoplasms, Second Primary
1
2001
92
0.170
Why?
Arabidopsis Proteins
1
2000
65
0.170
Why?
Immune System
1
2021
171
0.170
Why?
Pneumococcal Vaccines
1
2021
131
0.170
Why?
Biomarkers
6
2015
3397
0.170
Why?
Cell Self Renewal
1
2019
49
0.160
Why?
Species Specificity
1
2020
541
0.160
Why?
Mice, SCID
5
2021
312
0.160
Why?
Blast Crisis
2
2017
20
0.160
Why?
Interleukin-2 Receptor beta Subunit
1
2019
18
0.160
Why?
Combined Modality Therapy
5
2021
1117
0.160
Why?
Linkage Disequilibrium
2
2016
245
0.160
Why?
Pilot Projects
2
2021
1360
0.160
Why?
Prospective Studies
6
2023
6195
0.160
Why?
Radiotherapy Dosage
3
2016
243
0.160
Why?
Leukocytes, Mononuclear
1
2021
489
0.160
Why?
Lipopolysaccharide Receptors
1
2019
81
0.150
Why?
Busulfan
1
2018
14
0.150
Why?
Tomography, X-Ray Computed
3
2017
2272
0.150
Why?
HLA-DRB1 Chains
1
2018
97
0.150
Why?
Pediatrics
2
2019
982
0.150
Why?
Thyroid Neoplasms
1
2001
271
0.150
Why?
Telomere Homeostasis
1
2017
24
0.150
Why?
Cell Line
3
2011
2629
0.140
Why?
Homeostasis
1
2021
570
0.140
Why?
Ambulatory Care
1
2021
479
0.140
Why?
Proportional Hazards Models
3
2015
1078
0.140
Why?
Central Nervous System Neoplasms
1
2019
125
0.140
Why?
Epithelial Cell Adhesion Molecule
2
2016
10
0.140
Why?
Xenograft Model Antitumor Assays
4
2021
695
0.140
Why?
Antibodies, Neoplasm
1
2017
30
0.140
Why?
Vidarabine
4
2022
26
0.140
Why?
Receptors, Aryl Hydrocarbon
1
2017
39
0.140
Why?
Age Factors
5
2021
2885
0.140
Why?
Vascularized Composite Allotransplantation
1
2017
22
0.140
Why?
Dideoxynucleosides
1
2017
20
0.140
Why?
NK Cell Lectin-Like Receptor Subfamily B
1
2016
10
0.140
Why?
Receptors, OX40
1
2016
15
0.140
Why?
Roseolovirus Infections
1
2016
7
0.140
Why?
Lymphoma, Non-Hodgkin
2
2015
70
0.140
Why?
Antibodies, Monoclonal
3
2017
1257
0.140
Why?
5-Methylcytosine
1
2016
16
0.140
Why?
Herpesvirus 6, Human
1
2016
13
0.140
Why?
Secondary Prevention
3
2014
221
0.130
Why?
Chitinase-3-Like Protein 1
1
2016
17
0.130
Why?
Transplantation
1
2016
23
0.130
Why?
Whole Body Imaging
1
2016
19
0.130
Why?
Radiotherapy, Image-Guided
1
2016
30
0.130
Why?
Leuprolide
1
2016
19
0.130
Why?
Mortality
1
2018
283
0.130
Why?
Neoplastic Stem Cells
1
2019
327
0.130
Why?
Epitopes, T-Lymphocyte
1
2017
170
0.130
Why?
Immune System Diseases
1
2016
32
0.130
Why?
Sociobiology
1
2015
2
0.130
Why?
T-Lymphocyte Subsets
1
2018
383
0.130
Why?
Disease Models, Animal
3
2021
3498
0.130
Why?
Myeloid-Derived Suppressor Cells
1
2016
56
0.130
Why?
Interleukin-23 Subunit p19
1
2015
5
0.130
Why?
Ubiquitin-Protein Ligases
1
2016
139
0.130
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2015
16
0.120
Why?
Prostatic Neoplasms
2
2013
913
0.120
Why?
Positron-Emission Tomography
1
2017
260
0.120
Why?
Receptors, KIR2DL1
1
2015
18
0.120
Why?
Radiotherapy Planning, Computer-Assisted
2
2013
117
0.120
Why?
DNA Methylation
2
2016
493
0.120
Why?
Sirolimus
1
2016
181
0.120
Why?
Interleukin-2 Receptor alpha Subunit
1
2015
66
0.120
Why?
Sialic Acid Binding Ig-like Lectin 2
1
2015
11
0.120
Why?
Gene Expression Regulation, Developmental
1
2020
801
0.120
Why?
Cyclophosphamide
4
2014
214
0.120
Why?
Neutropenia
1
2015
123
0.120
Why?
Radiotherapy, Computer-Assisted
1
2014
12
0.120
Why?
Models, Biological
2
2020
1611
0.120
Why?
Gonadotropin-Releasing Hormone
1
2016
189
0.120
Why?
Ovary
1
2016
190
0.120
Why?
Radiation Dosage
1
2015
133
0.120
Why?
DNA Repair
1
2016
184
0.120
Why?
DNA, Viral
1
2016
349
0.120
Why?
Machine Learning
1
2018
315
0.120
Why?
Hypoglycemia
1
2019
386
0.120
Why?
Radiotherapy, Conformal
1
2014
68
0.120
Why?
Interleukin-8
1
2015
229
0.110
Why?
RNA, Messenger
4
2013
2550
0.110
Why?
Mice, Inbred NOD
4
2021
552
0.110
Why?
Dendritic Cells
1
2017
435
0.110
Why?
Infectious Disease Transmission, Vertical
1
1995
150
0.110
Why?
Arabinonucleosides
1
2013
8
0.110
Why?
Adenine Nucleotides
1
2013
18
0.110
Why?
Phantoms, Imaging
1
2014
123
0.110
Why?
Genetic Predisposition to Disease
3
2016
2090
0.110
Why?
Toll-Like Receptor 5
1
2013
14
0.110
Why?
Receptors, Notch
1
2014
83
0.110
Why?
CTLA-4 Antigen
1
2014
76
0.110
Why?
Embryonic Stem Cells
2
2017
106
0.110
Why?
Tomography, Spiral Computed
2
2014
23
0.110
Why?
Antiviral Agents
1
2019
642
0.110
Why?
Binding Sites
1
2016
1166
0.110
Why?
Clinical Protocols
1
2014
232
0.110
Why?
Recovery of Function
1
2017
573
0.110
Why?
Nuclear Receptor Subfamily 1, Group F, Member 3
1
2013
11
0.110
Why?
ADAM Proteins
1
2013
58
0.110
Why?
Body Size
1
2013
90
0.100
Why?
Pericardial Effusion
1
2013
21
0.100
Why?
Living Donors
1
2015
270
0.100
Why?
Interleukin-1beta
1
2015
368
0.100
Why?
Receptors, Cytokine
1
2013
33
0.100
Why?
Survivors
1
2016
412
0.100
Why?
Gene Expression Profiling
4
2020
1518
0.100
Why?
Enzyme-Linked Immunospot Assay
1
2012
34
0.100
Why?
Health Status Indicators
1
2013
155
0.100
Why?
Promoter Regions, Genetic
1
2016
1131
0.100
Why?
Cell Adhesion Molecules
1
2013
167
0.100
Why?
CD4 Lymphocyte Count
1
2012
256
0.100
Why?
Galectins
1
2012
22
0.100
Why?
Apolipoprotein C-III
2
2009
13
0.100
Why?
Antigens, Viral
1
2012
176
0.100
Why?
Antibody Formation
1
2013
266
0.100
Why?
Antigens, Neoplasm
1
2013
222
0.100
Why?
Ligands
3
2021
556
0.090
Why?
Healthcare Disparities
1
2017
479
0.090
Why?
Taxoids
1
2011
93
0.090
Why?
Blood Glucose
1
2020
1827
0.090
Why?
NK Cell Lectin-Like Receptor Subfamily D
1
2011
1
0.090
Why?
Oncogene Proteins, Fusion
1
2013
179
0.090
Why?
Antigens, CD20
1
2011
27
0.090
Why?
Proteoglycans
1
2011
107
0.090
Why?
Leukemia, Experimental
2
2009
27
0.090
Why?
Colonic Neoplasms
1
2013
212
0.090
Why?
Influenza, Human
1
2016
543
0.090
Why?
Colony-Forming Units Assay
1
2010
88
0.090
Why?
Observer Variation
1
2011
298
0.090
Why?
Bone and Bones
1
2013
277
0.090
Why?
Fas Ligand Protein
2
2001
57
0.090
Why?
Proto-Oncogene Proteins c-kit
1
2011
63
0.090
Why?
HL-60 Cells
3
2016
28
0.090
Why?
MicroRNAs
1
2016
600
0.090
Why?
Genotype
1
2015
1757
0.090
Why?
Umbilical Cord
1
2010
80
0.090
Why?
Serologic Tests
1
2009
47
0.080
Why?
Registries
2
2015
1764
0.080
Why?
Databases, Factual
1
2014
1125
0.080
Why?
Risk Assessment
4
2021
2958
0.080
Why?
Longitudinal Studies
2
2015
2384
0.080
Why?
Hydrocortisone
1
2010
267
0.080
Why?
Graft vs Host Reaction
1
2008
1
0.080
Why?
Head and Neck Neoplasms
1
2013
427
0.080
Why?
Glycosides
1
2009
33
0.080
Why?
Thoracic Vertebrae
1
2009
68
0.080
Why?
Leukemic Infiltration
1
2008
5
0.080
Why?
Membrane Glycoproteins
2
2001
429
0.080
Why?
Mice, Transgenic
1
2013
1947
0.070
Why?
NK Cell Lectin-Like Receptor Subfamily K
2
2005
4
0.070
Why?
Antibodies, Monoclonal, Humanized
2
2018
660
0.070
Why?
Monomeric GTP-Binding Proteins
1
2007
5
0.070
Why?
Case-Control Studies
4
2020
3003
0.070
Why?
Double-Blind Method
1
2011
1656
0.070
Why?
Active Transport, Cell Nucleus
1
2007
109
0.070
Why?
NFATC Transcription Factors
1
2007
78
0.070
Why?
Pregnancy Complications, Hematologic
1
2006
16
0.070
Why?
Bariatric Surgery
1
2009
160
0.070
Why?
Antigens, Differentiation
1
2006
79
0.070
Why?
Central Nervous System
1
2008
230
0.070
Why?
Liver Diseases
1
2009
254
0.070
Why?
Drug Monitoring
1
2007
184
0.070
Why?
Fibroma, Desmoplastic
1
2006
2
0.070
Why?
Hepatic Veno-Occlusive Disease
1
2006
11
0.060
Why?
Aged, 80 and over
4
2020
6306
0.060
Why?
Biomarkers, Tumor
3
2019
1032
0.060
Why?
Regression Analysis
1
2008
945
0.060
Why?
Reactive Oxygen Species
2
2020
522
0.060
Why?
Immunohistochemistry
2
2011
1624
0.060
Why?
Inflammation
1
2016
2464
0.060
Why?
Meningitis, Viral
1
2005
21
0.060
Why?
Metformin
1
2009
274
0.060
Why?
Calcium Signaling
1
2007
213
0.060
Why?
Anemia
1
2006
143
0.060
Why?
Immunity, Cellular
1
2007
247
0.060
Why?
RNA, Small Interfering
2
2005
534
0.060
Why?
Trastuzumab
1
2005
89
0.060
Why?
Vascular Endothelial Growth Factor A
2
2019
496
0.060
Why?
Mice, Knockout
2
2021
2562
0.060
Why?
Jurkat Cells
2
2017
128
0.060
Why?
Hemoglobins
1
2006
308
0.060
Why?
Cell Nucleus
1
2007
552
0.060
Why?
Phenotype
3
2021
2784
0.060
Why?
Plasma
1
2005
181
0.060
Why?
Feasibility Studies
2
2019
735
0.060
Why?
RNA Interference
1
2005
431
0.060
Why?
Postoperative Complications
2
2015
2122
0.060
Why?
Pregnancy
3
2010
5499
0.060
Why?
Immunocompromised Host
1
2005
192
0.050
Why?
Physicians
1
2011
765
0.050
Why?
Predictive Value of Tests
2
2018
1791
0.050
Why?
Liver
1
2011
1633
0.050
Why?
Sepsis
1
2009
507
0.050
Why?
Erythroid Precursor Cells
1
2003
4
0.050
Why?
c-Mer Tyrosine Kinase
1
2023
43
0.050
Why?
Enterovirus Infections
1
2005
160
0.050
Why?
beta-Thalassemia
1
2003
23
0.050
Why?
Oxidants
1
2003
112
0.050
Why?
Killer Cells, Lymphokine-Activated
1
2002
9
0.050
Why?
United States
3
2023
12137
0.050
Why?
Breast Neoplasms
1
2013
1846
0.050
Why?
In Vitro Techniques
1
2003
1003
0.050
Why?
Creatine Kinase
1
2001
75
0.050
Why?
Norpregnenes
1
2001
3
0.050
Why?
Werner Syndrome
1
2001
5
0.050
Why?
HIV Infections
1
1995
2453
0.050
Why?
Dactinomycin
1
2001
25
0.050
Why?
Femoral Neoplasms
1
2001
7
0.050
Why?
Luminescent Measurements
1
2002
74
0.050
Why?
Mice, Inbred BALB C
2
2001
1144
0.050
Why?
Thyroidectomy
1
2001
62
0.050
Why?
Perforin
1
2001
18
0.050
Why?
Vincristine
1
2001
98
0.050
Why?
Pore Forming Cytotoxic Proteins
1
2001
15
0.050
Why?
Thoracotomy
1
2001
73
0.050
Why?
Probability
2
2013
286
0.050
Why?
Immunization, Secondary
1
2021
82
0.040
Why?
Cycloheximide
1
2000
53
0.040
Why?
T-Lymphocytes, Cytotoxic
1
2001
154
0.040
Why?
Fatal Outcome
2
2005
281
0.040
Why?
Chemokines, CXC
1
2020
60
0.040
Why?
Lymphatic Metastasis
1
2001
275
0.040
Why?
Hospital Costs
1
2021
104
0.040
Why?
Pneumonia, Viral
1
2005
334
0.040
Why?
Fatty Acid Desaturases
1
2000
29
0.040
Why?
Tumor Microenvironment
1
2023
428
0.040
Why?
Random Allocation
1
2021
328
0.040
Why?
Chemotherapy, Adjuvant
1
2001
332
0.040
Why?
Methotrexate
1
2001
227
0.040
Why?
Creatinine
1
2001
424
0.040
Why?
Hodgkin Disease
1
2001
121
0.040
Why?
Doxorubicin
1
2001
286
0.040
Why?
Microtubule-Associated Proteins
1
2001
171
0.040
Why?
Placenta Growth Factor
1
2019
23
0.040
Why?
Base Sequence
1
2003
2114
0.040
Why?
Neuropeptides
1
2020
63
0.040
Why?
Cisplatin
1
2001
262
0.040
Why?
Eye Proteins
1
2020
70
0.040
Why?
Aging
1
2009
1611
0.040
Why?
Perioperative Period
1
2019
47
0.040
Why?
Cost of Illness
1
2021
254
0.040
Why?
Bleomycin
1
2001
228
0.040
Why?
Apoptosis Regulatory Proteins
1
2000
170
0.040
Why?
Gene Silencing
1
2020
171
0.040
Why?
Cell Compartmentation
1
2019
51
0.040
Why?
Microfilament Proteins
1
2020
125
0.040
Why?
Homozygote
1
2019
187
0.040
Why?
Loss of Heterozygosity
1
2018
40
0.040
Why?
Cost-Benefit Analysis
1
2021
544
0.040
Why?
Patient Safety
1
2021
273
0.040
Why?
Transforming Growth Factor beta
1
2020
445
0.040
Why?
Intracellular Signaling Peptides and Proteins
1
2020
388
0.040
Why?
Protein Phosphatase 2C
1
2017
14
0.030
Why?
Janus Kinase 2
1
2017
31
0.030
Why?
Infusions, Intravenous
1
2018
370
0.030
Why?
Daunorubicin
1
2016
24
0.030
Why?
Rhodamines
1
2016
16
0.030
Why?
Genes, p53
1
2017
61
0.030
Why?
Oxidative Stress
1
2003
1068
0.030
Why?
ZAP-70 Protein-Tyrosine Kinase
1
2016
8
0.030
Why?
Radiography, Dual-Energy Scanned Projection
1
2016
3
0.030
Why?
Premedication
1
2016
36
0.030
Why?
Ovarian Function Tests
1
2016
1
0.030
Why?
Obesity
1
2009
2505
0.030
Why?
Lung
1
2009
3521
0.030
Why?
Orthomyxoviridae
1
2016
35
0.030
Why?
Transplants
1
2016
36
0.030
Why?
ROC Curve
1
2018
441
0.030
Why?
CD4 Antigens
1
2016
123
0.030
Why?
Validation Studies as Topic
1
2016
23
0.030
Why?
Calcineurin Inhibitors
1
2016
58
0.030
Why?
Receptors, Virus
1
2016
75
0.030
Why?
Growth Substances
1
2016
138
0.030
Why?
Dose-Response Relationship, Radiation
1
2016
127
0.030
Why?
Myeloproliferative Disorders
1
2016
26
0.030
Why?
Macrophages
1
2023
1259
0.030
Why?
HLA-B Antigens
1
2016
56
0.030
Why?
HT29 Cells
1
2016
35
0.030
Why?
ras Proteins
1
2017
138
0.030
Why?
Antibiotics, Antineoplastic
1
2016
110
0.030
Why?
Th1 Cells
1
2016
123
0.030
Why?
Neoplasm Grading
1
2016
241
0.030
Why?
Repetitive Sequences, Nucleic Acid
1
2016
104
0.030
Why?
Outpatients
1
2019
325
0.030
Why?
DNA Mutational Analysis
1
2017
373
0.030
Why?
Extracellular Signal-Regulated MAP Kinases
1
2016
157
0.030
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
2
2006
134
0.030
Why?
Nuclear Proteins
1
2020
591
0.030
Why?
Dose-Response Relationship, Drug
2
2015
1836
0.030
Why?
Biological Transport
1
2016
374
0.030
Why?
Angiopoietin-2
1
2015
11
0.030
Why?
Follicle Stimulating Hormone
1
2016
216
0.030
Why?
Protein Transport
1
2016
391
0.030
Why?
Cadaver
1
2016
298
0.030
Why?
History, 21st Century
1
2016
160
0.030
Why?
Immunotoxins
1
2015
33
0.030
Why?
Precursor Cells, B-Lymphoid
1
2015
34
0.030
Why?
Blotting, Western
2
2011
1143
0.030
Why?
International Cooperation
1
2015
169
0.030
Why?
Jaw
1
2014
16
0.030
Why?
History, 20th Century
1
2016
265
0.030
Why?
Reproducibility of Results
2
2016
2764
0.030
Why?
Diagnostic Errors
1
1995
150
0.030
Why?
Antibody-Dependent Cell Cytotoxicity
1
2014
19
0.030
Why?
Models, Molecular
1
2019
1368
0.030
Why?
Computer Simulation
1
2018
873
0.030
Why?
Hydroxamic Acids
1
2014
80
0.030
Why?
Lung Neoplasms
2
2009
2159
0.030
Why?
Bones of Upper Extremity
1
2013
3
0.030
Why?
Transplantation, Heterologous
1
2014
180
0.030
Why?
Etoposide
1
2013
149
0.030
Why?
Spiro Compounds
1
2013
9
0.030
Why?
Antimetabolites, Antineoplastic
1
2013
80
0.030
Why?
Autoimmunity
1
2019
812
0.030
Why?
ADAM17 Protein
1
2013
30
0.030
Why?
Pericardiocentesis
1
2013
9
0.030
Why?
Azacitidine
1
2014
129
0.030
Why?
Calcium-Binding Proteins
1
2014
205
0.030
Why?
Receptors, Cell Surface
1
2015
350
0.030
Why?
Myeloid Cells
1
2014
126
0.030
Why?
Academic Medical Centers
1
2015
405
0.030
Why?
Immunoglobulin Fragments
1
2012
15
0.030
Why?
Intercellular Signaling Peptides and Proteins
1
2014
347
0.030
Why?
Epigenesis, Genetic
1
2016
518
0.030
Why?
Global Health
1
2014
284
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2007
924
0.020
Why?
Femur
1
2013
191
0.020
Why?
Kinetics
1
2015
1547
0.020
Why?
Receptors, KIR2DL2
1
2011
6
0.020
Why?
Receptors, KIR2DL3
1
2011
8
0.020
Why?
Spine
1
2013
136
0.020
Why?
Terminology as Topic
1
2013
186
0.020
Why?
Remission, Spontaneous
1
2011
37
0.020
Why?
Sensitivity and Specificity
1
2016
1690
0.020
Why?
Immune Tolerance
1
2014
321
0.020
Why?
Piperidines
1
2013
159
0.020
Why?
Immunocompetence
1
2011
40
0.020
Why?
Lysosomal-Associated Membrane Protein 1
1
2011
5
0.020
Why?
Stem Cells
1
2016
541
0.020
Why?
ABO Blood-Group System
1
2011
29
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2016
1145
0.020
Why?
Colorado
1
2021
4090
0.020
Why?
Drug Synergism
1
2011
315
0.020
Why?
Algorithms
1
2018
1469
0.020
Why?
Real-Time Polymerase Chain Reaction
1
2011
314
0.020
Why?
Antilymphocyte Serum
1
2010
60
0.020
Why?
Seasons
1
2013
440
0.020
Why?
Epitopes
1
2012
434
0.020
Why?
Genome-Wide Association Study
1
2016
1176
0.020
Why?
Leukocyte Immunoglobulin-like Receptor B1
1
2010
2
0.020
Why?
B-Lymphocytes
1
2015
762
0.020
Why?
HEK293 Cells
1
2012
590
0.020
Why?
Virus Replication
1
2011
395
0.020
Why?
Tumor Necrosis Factor-alpha
1
2014
1128
0.020
Why?
Recombinant Proteins
1
2012
1228
0.020
Why?
Quality of Life
1
2019
2343
0.020
Why?
Mice, Inbred C57BL
2
2011
4680
0.020
Why?
Cranial Irradiation
1
2008
66
0.020
Why?
Protein Isoforms
1
2009
337
0.020
Why?
Radiotherapy, Adjuvant
1
2008
182
0.020
Why?
Umbilical Veins
1
2007
57
0.020
Why?
Granzymes
1
2007
40
0.020
Why?
Apolipoprotein C-I
1
2006
1
0.020
Why?
Complement C1 Inactivator Proteins
1
2006
6
0.020
Why?
Apolipoproteins C
1
2006
6
0.020
Why?
Serum Amyloid A Protein
1
2006
29
0.020
Why?
Prealbumin
1
2006
22
0.020
Why?
Minnesota
1
2007
132
0.020
Why?
Maternal Age
1
2006
116
0.020
Why?
Blood Transfusion
1
2008
265
0.020
Why?
DNA Primers
1
2007
508
0.020
Why?
Peptide Mapping
1
2005
60
0.020
Why?
Endotoxins
1
2006
211
0.020
Why?
Transduction, Genetic
1
2005
113
0.020
Why?
Kidney Neoplasms
1
2009
324
0.020
Why?
Liver Neoplasms
1
2009
504
0.020
Why?
Disease Progression
1
2011
2371
0.010
Why?
Reference Values
1
2006
739
0.010
Why?
Glycoproteins
1
2006
304
0.010
Why?
Universities
1
2007
338
0.010
Why?
Lung Transplantation
1
2006
244
0.010
Why?
Bronchoalveolar Lavage Fluid
1
2006
580
0.010
Why?
Chromatography, High Pressure Liquid
1
2005
465
0.010
Why?
Odds Ratio
1
2006
951
0.010
Why?
Cell Membrane
1
2007
670
0.010
Why?
Annexin A5
1
2003
22
0.010
Why?
Adaptor Proteins, Signal Transducing
1
2005
367
0.010
Why?
Caspase 8
1
2003
43
0.010
Why?
Erythropoiesis
1
2003
33
0.010
Why?
Anion Exchange Protein 1, Erythrocyte
1
2003
22
0.010
Why?
Membrane Potentials
1
2003
247
0.010
Why?
Cytoskeletal Proteins
1
2003
145
0.010
Why?
Proteome
1
2005
337
0.010
Why?
Leukemia, B-Cell
1
2002
11
0.010
Why?
Hemolysis
1
2003
143
0.010
Why?
Caspases
1
2003
243
0.010
Why?
Luciferases
1
2002
142
0.010
Why?
Creatine
1
2001
51
0.010
Why?
Hypoglycemic Agents
1
2009
1011
0.010
Why?
Tissue Distribution
1
2001
285
0.010
Why?
Immunoblotting
1
2001
282
0.010
Why?
Inhibitor of Apoptosis Proteins
1
2001
42
0.010
Why?
RNA
1
2007
806
0.010
Why?
Diabetes Mellitus
1
2009
898
0.010
Why?
Blood Proteins
1
2003
222
0.010
Why?
Luminescent Proteins
1
2002
166
0.010
Why?
Neoplasm Transplantation
1
2001
227
0.010
Why?
Hydrogen-Ion Concentration
1
2001
507
0.010
Why?
Green Fluorescent Proteins
1
2002
370
0.010
Why?
Cell Death
1
2001
322
0.010
Why?
Thymus Gland
1
2001
296
0.010
Why?
Tumor Cells, Cultured
1
2001
845
0.010
Why?
Cell Division
1
2001
754
0.010
Why?
Transfection
1
2002
863
0.010
Why?
Spleen
1
2001
485
0.010
Why?
Phosphorylation
1
2001
1558
0.010
Why?
Gene Expression
1
2001
1417
0.010
Why?
Verneris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)